 Connection
Naresh Mandava to Bevacizumab
This is a "connection" page, showing publications Naresh Mandava has written about Bevacizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.420 |
|
|
|
-
Dixon JA, Oliver SC, Olson JL, Mandava N. VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2009 Oct; 18(10):1573-80.
Score: 0.081
-
Kahook MY, Kimura AE, Wong LJ, Ammar DA, Maycotte MA, Mandava N. Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging. 2009 May-Jun; 40(3):293-5.
Score: 0.079
-
Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007 Sep; 27(3):238-40.
Score: 0.070
-
Salcedo-Villanueva G, Harasawa M, Velez-Montoya R, Mathias MT, Siringo FS, Olson JL, Oliver SC, Mandava N, Quiroz-Mercado H. Spectral domain optical coherence tomographic analysis of healthy retina in branch retinal vein occlusion and its response to antiangiogenic therapy. Retina. 2015 Apr; 35(4):704-14.
Score: 0.030
-
Velez-Montoya R, Oliver SC, Olson JL, Fine SL, Mandava N, Quiroz-Mercado H. Current knowledge and trends in age-related macular degeneration: today's and future treatments. Retina. 2013 Sep; 33(8):1487-502.
Score: 0.027
-
Ernst BJ, Garc?a-Aguirre G, Oliver SC, Olson JL, Mandava N, Quiroz-Mercado H. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-na?ve proliferative and severe nonproliferative diabetic retinopathy. Acta Ophthalmol. 2012 Nov; 90(7):e573-4.
Score: 0.024
-
Pan CK, Durairaj C, Kompella UB, Agwu O, Oliver SC, Quiroz-Mercado H, Mandava N, Olson JL. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model. J Ocul Pharmacol Ther. 2011 Jun; 27(3):219-24.
Score: 0.023
-
Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci. 2011 Feb; 52(2):1023-34.
Score: 0.022
-
Horsley MB, Mandava N, Maycotte MA, Kahook MY. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2010 Oct; 150(4):558-561.e1.
Score: 0.022
-
Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol. 2011 Aug; 95(8):1111-4.
Score: 0.022
-
Kahook MY, Liu L, Ruzycki P, Mandava N, Carpenter JF, Petrash JM, Ammar DA. High-molecular-weight aggregates in repackaged bevacizumab. Retina. 2010 Jun; 30(6):887-92.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|